459 related articles for article (PubMed ID: 32503084)
1. Miller-Fisher syndrome after SARS-CoV-2 infection.
Reyes-Bueno JA; García-Trujillo L; Urbaneja P; Ciano-Petersen NL; Postigo-Pozo MJ; Martínez-Tomás C; Serrano-Castro PJ
Eur J Neurol; 2020 Sep; 27(9):1759-1761. PubMed ID: 32503084
[TBL] [Abstract][Full Text] [Related]
2. [Clinical cases of Guillain-Barré and Miller-Fisher syndromes linked to COVID-19].
Jasso-Rangel M; Vargas-Martínez KO; Camacho-Frausto LY; Galindo-Félix A; Román-Esquivel JV; Lara-Ramírez EE
Rev Med Inst Mex Seguro Soc; 2022 Feb; 60(1):91-95. PubMed ID: 35274917
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2-associated Guillain-Barré syndrome in four patients: what do we know about pathophysiology?
Guilmot A; Maldonado Slootjes S; Bissay V; Dubuisson N; de Broglie C; Gille M
Acta Neurol Belg; 2022 Jun; 122(3):703-707. PubMed ID: 34476752
[TBL] [Abstract][Full Text] [Related]
4. Miller-Fisher syndrome after COVID-19: neurochemical markers as an early sign of nervous system involvement.
Senel M; Abu-Rumeileh S; Michel D; Garibashvili T; Althaus K; Kassubek J; Otto M
Eur J Neurol; 2020 Nov; 27(11):2378-2380. PubMed ID: 32781484
[TBL] [Abstract][Full Text] [Related]
5. A unique case of Miller Fisher-Guillain-Barré overlap syndrome in a liver transplant recipient.
Ramirez-Sanchez C; Syed R; Meier A; LaBuzetta JN; Hylton DJ; Taremi M
J Neurovirol; 2021 Oct; 27(5):797-801. PubMed ID: 34550544
[TBL] [Abstract][Full Text] [Related]
6. Retrospective analysis of COVID-19 patients with Guillain-Barre, Miller-Fisher, and opsoclonus-myoclonus-ataxia syndromes-a case series.
Olbert E; Alhani N; Struhal W
Wien Med Wochenschr; 2024 Feb; 174(1-2):30-34. PubMed ID: 37523107
[TBL] [Abstract][Full Text] [Related]
7. Miller Fischer and posterior reversible encephalopathy syndromes post COVID-19 infection.
Al Haboob AA
Neurosciences (Riyadh); 2021 Jul; 26(3):295-299. PubMed ID: 34230086
[TBL] [Abstract][Full Text] [Related]
8. Miller-Fisher syndrome associated with SARS-CoV-2: a case report.
Faulkner L; Scott S; Flint N
Microbes Infect; 2022; 24(5):104954. PubMed ID: 35240290
[TBL] [Abstract][Full Text] [Related]
9. Delayed onset Bickerstaff brainstem encephalitis overlapping Miller-Fisher Syndrome during SARS-CoV-2 infection.
Acampora R; de Falco A; Lanfranchi F; Montella S; Scala R; Lieto M; Durante L; Bruno R
Neurol Sci; 2023 Dec; 44(12):4179-4182. PubMed ID: 37889381
[TBL] [Abstract][Full Text] [Related]
10. Miller Fisher syndrome diagnosis and treatment in a patient with SARS-CoV-2.
Manganotti P; Pesavento V; Buoite Stella A; Bonzi L; Campagnolo E; Bellavita G; Fabris B; Luzzati R
J Neurovirol; 2020 Aug; 26(4):605-606. PubMed ID: 32529516
[TBL] [Abstract][Full Text] [Related]
11. Miller Fisher Syndrome Following Vaccination against SARS-CoV-2.
Yamakawa M; Nakahara K; Nakanishi T; Nomura T; Ueda M
Intern Med; 2022; 61(7):1067-1069. PubMed ID: 35370249
[TBL] [Abstract][Full Text] [Related]
12. Miller Fisher syndrome associated with COVID-19: an up-to-date systematic review.
Li Z; Li X; Shen J; Chan MTV; Wu WKK
Environ Sci Pollut Res Int; 2021 May; 28(17):20939-20944. PubMed ID: 33677662
[TBL] [Abstract][Full Text] [Related]
13. Miller Fischer syndrome after COVID-19 infection and vaccine: a systematic review.
Neophytou P; Artemiadis A; Hadjigeorgiou GM; Zis P
Acta Neurol Belg; 2023 Oct; 123(5):1693-1701. PubMed ID: 37468803
[TBL] [Abstract][Full Text] [Related]
14. Miller Fisher syndrome possibly related to mycoplasma pneumoniae infection: report of one case.
Hsueh KC; Chou IC; Hsu CH; Kuo HT; Tsai FJ; Tsai CH
Acta Paediatr Taiwan; 2004; 45(3):168-70. PubMed ID: 15493737
[TBL] [Abstract][Full Text] [Related]
15. Miller-Fisher Syndrome and Guillain-Barre Syndrome overlap syndrome in a patient post Oxford-AstraZeneca SARS-CoV-2 vaccination.
Dang YL; Bryson A
BMJ Case Rep; 2021 Nov; 14(11):. PubMed ID: 34848426
[TBL] [Abstract][Full Text] [Related]
16. A case report of thrombocytopenic COVID-19 and Miller-Fisher syndrome on a concurrent chronic immune neuropathy.
Blackbourn L; Hamid U; Tokala J; Blume G
Medicine (Baltimore); 2024 May; 103(21):e38304. PubMed ID: 38788032
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics and prognosis of temporary miller fisher syndrome following COVID-19 vaccination: a systematic review of case studies.
Alijanzadeh D; Soltani A; Afra F; Salmanpour F; Loghman AH; Samieefar N; Rezaei N
BMC Neurol; 2023 Sep; 23(1):332. PubMed ID: 37735648
[TBL] [Abstract][Full Text] [Related]
18. Guillain-Barré/Miller Fisher overlap syndrome in a patient after coronavirus disease-2019 infection: a case report.
Mohammadi SM; Abdi R; Karimi Z; Mortazavi F
J Med Case Rep; 2022 Feb; 16(1):63. PubMed ID: 35135595
[TBL] [Abstract][Full Text] [Related]
19. COVID-19-Associated Miller Fisher Syndrome: MRI Findings.
Lantos JE; Strauss SB; Lin E
AJNR Am J Neuroradiol; 2020 Jul; 41(7):1184-1186. PubMed ID: 32467190
[TBL] [Abstract][Full Text] [Related]
20. Miller Fisher syndrome following BNT162b2 mRNA coronavirus 2019 vaccination.
Nishiguchi Y; Matsuyama H; Maeda K; Shindo A; Tomimoto H
BMC Neurol; 2021 Nov; 21(1):452. PubMed ID: 34789193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
